Financials
Income statement
Fiscal date | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
---|---|---|---|---|
Total reported revenue | 2.4T | 2.2T | 2T | 1.6T |
Cost of revenue | -1.0T | 1.7T | 1.6T | 1.3T |
Gross profit | 3.5T | 480B | 433B | 312B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | -33B | 53B | 66B | 63B |
Other operating expenses | 3.0T | 23B | 21B | 20B |
Operating income | 437B | 404B | 346B | 229B |
Non operating interest income | ||||
Income | 34B | 39B | 28B | 28B |
Expense | 74B | 54B | 49B | 52B |
Other income expense | — | — | — | — |
Pretax income | 304B | 414B | 326B | 208B |
Tax provision | 68B | 69B | 63B | 40B |
Net income | 236B | 345B | 263B | 168B |
Basic EPS | — | 33.1 | 24.5 | 15.7 |
Diluted EPS | — | 33.1 | 24.5 | 15.7 |
Basic average shares | — | 9.5B | 9.5B | 9.5B |
Diluted average shares | — | 9.5B | 9.5B | 9.5B |
EBITDA | 521B | 651B | 561B | 418B |
Net income from continuing op. | 236B | 345B | 263B | 168B |
Minority interests | -49B | -31B | -30B | -19B |
Preferred stock dividends | 0 | 0 | 0 | 0 |